User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin

Primary tabs

download
  • Open access
  • PDF
  • 699.77 K
Marquez, Béatrice [UCL] Ameye, Geneviève [UCL] Vallet, Coralie M. [UCL] Tulkens, Paul M. [UCL] Poirel, Hélène A. [UCL] Van Bambeke, Françoise [UCL]

Exposure of J774 mouse macrophages to stepwise increasing concentrations of ciprofloxacin, an antibiotic inhibiting bacterial topoisomerases, selects for resistant cells that overexpress the efflux transporter Abcc4 (Marquez et al. [2009] Antimicrob. Agents Chemother. 53: 2410-2416), encoded by the Abcc4 gene located on Chromosome 14qE4. In this study, we report the genomic alterations occurring along the selection process. Abcc4 expression progressively increased upon selection rounds, with exponential changes observed between cells exposed to 150 and 200 µM of ciprofloxacin, accompanied by a commensurate decrease in ciprofloxacin accumulation. Molecular cytogenetics experiments showed that this overexpression is linked to Abcc4 gene overrepresentation, grading from a partial trisomy of Chr 14 at the first step of selection (cells exposed to 100 µM ciprofloxacin), to low-level amplifications (around three copies) of Abcc4 locus on 1 or 2 Chr 14 (cells exposed to 150 µM ciprofloxacin), followed by high-level amplification of Abcc4 as homogeneous staining region (hsr), inserted on 3 different derivative Chromosomes (cells exposed to 200 µM ciprofloxacin). In revertant cells obtained after more than 60 passages of culture without drug, the Abcc4 hsr amplification was lost in approx. 70% of the population. These data suggest that exposing cells to sufficient concentrations of an antibiotic with low affinity for eukaryotic topoisomerases can cause major genomic alterations that may lead to the overexpression of the transporter responsible for its efflux. Gene amplification appears therefore as a mechanism of resistance that can be triggered by non-anticancer agents but contribute to cross-resistance, and is partially and slowly reversible.

Document type Article de périodique (Journal article) – Journal Article, Research Support, Non-U.S. Gov't
Access type Accès libre
Publication date 2011
Language Anglais
Journal information "PLoS One" - Vol. 6, no. 12, p. e28368 (2011)
Peer reviewed yes
Publisher Public Library of Science ((United States) San Francisco, CA)
issn 1932-6203
Publication status Publié
Affiliations UCL - SSS/LDRI - Louvain Drug Research Institute
UCL - (SLuc) Centre de génétique médicale UCL
Links
  1. Eckford Paul D. W., Sharom Frances J., ABC Efflux Pump-Based Resistance to Chemotherapy Drugs, 10.1021/cr9000226
  2. Marquez Beatrice, Van Bambeke Francoise, ABC Multidrug Transporters: Target for Modulation of Drug Pharmacokinetics and Drug-Drug Interactions, 10.2174/138945011795378504
  3. Lee Wan, Choi Hyo-Im, Kim Mi-Jin, Park Seung-Yoon, Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability, 10.3858/emm.2008.40.1.109
  4. Calcagno A M, Fostel J M, To K K W, Salcido C D, Martin S E, Chewning K J, Wu C-P, Varticovski L, Bates S E, Caplen N J, Ambudkar S V, Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes, 10.1038/sj.bjc.6604334
  5. Baker Emma K, Johnstone Ricky W, Zalcberg John R, El-Osta Assam, Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs, 10.1038/sj.onc.1208955
  6. Albertson Donna G., Gene amplification in cancer, 10.1016/j.tig.2006.06.007
  7. Mottino Aldo-D, Hepatic drug transporters and nuclear receptors: Regulation by therapeutic agents, 10.3748/wjg.14.7068
  8. FOJO T, Multiple paths to a drug resistance phenotype: Mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNAs☆, 10.1016/j.drup.2007.02.002
  9. Yasui Kohichiroh, Mihara Saori, Zhao Chen, Okamoto Hiroyuki, Saito-Ohara Fumiko, Tomida Akihiro, Funato Tadao, Yokomizo Akira, Naito Seiji, Imoto Issei, Tsuruo Takashi, Inazawa Johji, Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance, 10.1158/0008-5472.can-3263-2
  10. Rund Deborah, Azar Idit, Shperling Olga, A Mutation in the Promoter of the Multidrug Resistance Gene (MDR1) in Human Hematological Malignancies may Contribute to the Pathogenesis of Resistant Disease, Drug Resistance in Leukemia and Lymphoma III (1999) ISBN:9781461371809 p.71-75, 10.1007/978-1-4615-4811-9_9
  11. Knutsen Turid, Mickley Lyn A., Ried Thomas, Green Eric D., du Manoir Stanislas, Schröck Evelin, Macville Merryn, Ning Yi, Robey Robert, Polymeropoulos Mihael, Torres Rosarelis, Fojo Tito, Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene,MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL, 10.1002/(sici)1098-2264(199809)23:1<44::aid-gcc7>3.0.co;2-6
  12. Choi H. K., Yang J. W., Roh S. H., Han C. Y., Kang K. W., Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells, 10.1677/erc-06-0016
  13. RUSSEL F, KOENDERINK J, MASEREEUW R, Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules, 10.1016/j.tips.2008.01.006
  14. Belinsky M. G., Guo P., Lee K., Zhou F., Kotova E., Grinberg A., Westphal H., Shchaveleva I., Klein-Szanto A., Gallo J. M., Kruh G. D., Multidrug Resistance Protein 4 Protects Bone Marrow, Thymus, Spleen, and Intestine from Nucleotide Analogue-Induced Damage, 10.1158/0008-5472.can-06-2680
  15. Krishnamurthy P., Schwab M., Takenaka K., Nachagari D., Morgan J., Leslie M., Du W., Boyd K., Cheok M., Nakauchi H., Marzolini C., Kim R. B., Poonkuzhali B., Schuetz E., Evans W., Relling M., Schuetz J. D., Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity, 10.1158/0008-5472.can-07-6790
  16. Ho Lye Lin, Kench James G., Handelsman David J., Scheffer George L., Stricker Phillip D., Grygiel John G., Sutherland Robert L., Henshall Susan M., Allen John D., Horvath Lisa G., Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer, 10.1002/pros.20809
  17. Peng Xing-Xiang, Shi Zhi, Damaraju Vijaya L., Huang Xiao-Cong, Kruh Gary D., Wu Hsiang-Chun, Zhou Ying, Tiwari Amit, Fu Liwu, Cass Carol E., Chen Zhe-Sheng, Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine, 10.1016/j.leukres.2007.09.015
  18. Norris M. D., Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro, 10.1158/1535-7163.mct-04-0161
  19. Ansari M., Sauty G., Labuda M., Gagne V., Laverdiere C., Moghrabi A., Sinnett D., Krajinovic M., Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia, 10.1182/blood-2008-11-191098
  20. Schuetz John D., Connelly Michele C., Sun Daxi, Paibir Sheela G., Flynn Patricia M., Srinivas R.V., Kumar Alok, Fridland Arnold, 10.1038/12487
  21. Marquez B., Caceres N. E., Mingeot-Leclercq M.-P., Tulkens P. M., Van Bambeke F., Identification of the Efflux Transporter of the Fluoroquinolone Antibiotic Ciprofloxacin in Murine Macrophages: Studies with Ciprofloxacin-Resistant Cells, 10.1128/aac.01428-08
  22. Tulkens P. M., Intracellular distribution and activity of antibiotics, 10.1007/bf01964420
  23. Albertini Silvio, Chételat Andrée-Anne, Miller Beate, Muster Wolfgang, Pujadas Eva, Strobel Renate, Gocke Elmar, Genotoxicity of 17 gyrase- and four mammalian topoisomerase II-poisons in prokaryotic and eukaryotic test systems, 10.1093/mutage/10.4.343
  24. SH Elsea, J Biol Chem, 267, 13150 (1992)
  25. Lynch A., Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity, 10.1093/mutage/geg003
  26. Gottesman Michael M., Cardarelli Carol, Goldenberg Sarah, Licht Thomas, Pastan Ira, [17] Selection and maintenance of multidrug-resistant cells, Methods in Enzymology (1998) ISBN:9780121821937 p.248-258, 10.1016/s0076-6879(98)92019-5
  27. Michot J.-M., Heremans M. F., Caceres N. E., Mingeot-Leclercq M.-P., Tulkens P. M., Van Bambeke F., Cellular Accumulation and Activity of Quinolones in Ciprofloxacin-Resistant J774 Macrophages, 10.1128/aac.50.5.1689-1695.2006
  28. Wielinga P. R., Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney Cells, 10.1124/mol.62.6.1321
  29. IS Haslam, Drug Metab Dispos Epub ahead of print (2011)
  30. ML Slovak, Leukemia, 2, 453 (1988)
  31. Rao V. Koneti, Wangsa Darawalee, Robey Robert W., Huff Lyn, Honjo Yasumasa, Hung Jeffrey, Knutsen Turid, Ried Thomas, Bates Susan E., Characterization of ABCG2 gene amplification manifesting as extrachromosomal DNA in mitoxantrone-selected SF295 human glioblastoma cells, 10.1016/j.cancergencyto.2004.12.013
  32. ML Slovak, Cancer Res, 53, 3221 (1993)
  33. Lepage P, Devault A, Gros P, Activation of the mouse mdr3 gene by insertion of retroviruses in multidrug-resistant P388 tumor cells., 10.1128/mcb.13.12.7380
  34. Mickley L A, Spengler B A, Knutsen T A, Biedler J L, Fojo T, Gene rearrangement: a novel mechanism for MDR-1 gene activation., 10.1172/jci119362
  35. Helmrich A., Stout-Weider K., Hermann K., Schrock E., Heiden T., Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes, 10.1101/gr.5335506
  36. Drlica K., Malik M., Kerns R. J., Zhao X., Quinolone-Mediated Bacterial Death, 10.1128/aac.01617-06
  37. Herbold Bernd A, Brendler-Schwaab Susanne Y, Ahr Hans Jürgen, Ciprofloxacin: in vivo genotoxicity studies, 10.1016/s1383-5718(01)00275-3
  38. Rosen J.E., Schluter G., Williams G.M., Lack of Effects of Ciprofloxacin and the Topoisomerase II Inhibitors,m-AMSA and Nalidixic Acid, on DNA Repair in Cultured Rat Liver Cells, 10.1006/taap.1996.0220
  39. Mitelman F, Kolnig A M, Strombeck B, Norrby R, Kromann-Andersen B, Sommer P, Wadstein J, No cytogenetic effects of quinolone treatment in humans., 10.1128/aac.32.6.936
  40. Gorla N, Garcı́a Ovando H, Larripa I, Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin, 10.1016/s0378-4274(98)00230-6
  41. Anupama M., Seiler J. P., Murthy P. B., A comparative analysis of chromosomal aberrations in cultured human lymphocytes due to fluoroquinolone drugs at different expression periods, 10.1007/s00204-009-0509-9
  42. Mukherjee A., Sen S., Agarwal K., Ciprofloxacin: mammalian DNA topoisomerase type II poison in vivo, 10.1016/0165-7992(93)90029-u
  43. Itoh Tadashi, Mitsumori Kunitoshi, Kawaguchi Satomi, Sasaki Yu F., Genotoxic potential of quinolone antimicrobials in the in vitro comet assay and micronucleus test, 10.1016/j.mrgentox.2005.11.003
  44. Itoh Satoru, Nakayama Shiho, Shimada Hiroyasu, In vitro photochemical clastogenicity of quinolone antibacterial agents studied by a chromosomal aberration test with light irradiation, 10.1016/s1383-5718(02)00058-x
  45. Procedure No. EMEA/H/C/995, 1 (2009)
  46. Foroumadi Alireza, Emami Saeed, Rajabalian Saeed, Badinloo Marziyeh, Mohammadhosseini Negar, Shafiee Abbas, N-Substituted piperazinyl quinolones as potential cytotoxic agents: Structure–activity relationships study, 10.1016/j.biopha.2008.01.016
  47. S Rajabalian, J Pharm Pharm Sci, 10, 153 (2007)
  48. R Snyderman, J Immunol, 119, 2060 (1977)
  49. Michot J.-M., Van Bambeke F., Mingeot-Leclercq M.-P., Tulkens P. M., Active Efflux of Ciprofloxacin from J774 Macrophages through an MRP-Like Transporter, 10.1128/aac.48.7.2673-2682.2004
  50. Michot J.-M., Seral C., Van Bambeke F., Mingeot-Leclercq M.-P., Tulkens P. M., Influence of Efflux Transporters on the Accumulation and Efflux of Four Quinolones (Ciprofloxacin, Levofloxacin, Garenoxacin, and Moxifloxacin) in J774 Macrophages, 10.1128/aac.49.6.2429-2437.2005
  51. OH Lowry, J Biol Chem, 193, 265 (1951)
  52. Pfaffl M. W., A new mathematical model for relative quantification in real-time RT-PCR, 10.1093/nar/29.9.e45
  53. Lee James J., Warburton Dorothy, Robertson Elizabeth J., Cytogenetic methods for the mouse: Preparation of chromosomes, karyotyping, and in situ hybridization, 10.1016/0003-2697(90)90036-9
  54. Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison C J, Mugneret F, Bahloula K, Struski S, Grégoire M J, Nadal N, Lippert E, Taviaux S, Simons A, Kuiper R P, Moorman A V, Barber K, Bosly A, Michaux L, Vandenberghe P, Lahortiga I, De Keersmaecker K, Wlodarska I, Cools J, Hagemeijer A, Poirel H A, Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia, 10.1038/leu.2008.278
Bibliographic reference Marquez, Béatrice ; Ameye, Geneviève ; Vallet, Coralie M. ; Tulkens, Paul M. ; Poirel, Hélène A. ; et. al. Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin. In: PLoS One, Vol. 6, no. 12, p. e28368 (2011)
Permanent URL http://hdl.handle.net/2078.1/106867